Search Results
Department of Clinical Sciences, Lund University, Lund, Sweden
Search for other papers by Bengt Hallengren in
Google Scholar
PubMed
Department of Clinical Sciences, Lund University, Lund, Sweden
Search for other papers by Tereza Planck in
Google Scholar
PubMed
Department of Clinical Sciences, Lund University, Lund, Sweden
Search for other papers by Peter Åsman in
Google Scholar
PubMed
Department of Clinical Sciences, Lund University, Lund, Sweden
Search for other papers by Mikael Lantz in
Google Scholar
PubMed
SAT is very rare, and only a limited number of cases of GD occurring after SAT have been reported [ 2 , 3 , 4 , 5 , 6 ]. Here, we report a case of GD with opthalmopathy occurring 11 years after SAT with thyroid-stimulating hormone (TSH) receptor
Department of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead, United Kingdom
Search for other papers by Salman Razvi in
Google Scholar
PubMed
Search for other papers by Vicky Ryan in
Google Scholar
PubMed
Department of Endocrinology, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom
Search for other papers by Lorna Ingoe in
Google Scholar
PubMed
Department of Endocrinology, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom
Search for other papers by Simon H. Pearce in
Google Scholar
PubMed
Search for other papers by Scott Wilkes in
Google Scholar
PubMed
treated as a homogenous group irrespective of age to aim for serum thyroid-stimulating Hormone (TSH) levels within the population reference range (generally in the range of 0.4–4.0 mU/L) [ 8 ]. But, thyroxine metabolism is altered in advanced age, and “age
Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed
Search for other papers by Peter Laurberg in
Google Scholar
PubMed
Introduction Neonatal hyperthyroidism is a rare disease. Most cases are due to placental transferal of thyroid-stimulating hormone (TSH) receptor autoantibodies (TRAb) from mothers with Graves' disease to their fetuses. Even rarer causes are
Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Lars Folkestad in
Google Scholar
PubMed
Search for other papers by Frans Brandt in
Google Scholar
PubMed
Search for other papers by Thomas Brix in
Google Scholar
PubMed
Search for other papers by Marianne Vogsen in
Google Scholar
PubMed
Search for other papers by Lars Bastholt in
Google Scholar
PubMed
Search for other papers by Peter Grupe in
Google Scholar
PubMed
Search for other papers by Jeanette Krogh Petersen in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
-existing GD and metastatic papillary thyroid adenocarcinoma of follicular type, had TRAB stimulation of the metastatic thyroid tissue, causing this highly differentiated tumor tissue to produce uncontrolled amounts of thyroid hormones. As the first
Search for other papers by Tanvir Rizvi in
Google Scholar
PubMed
Search for other papers by Patrice K. Rehm in
Google Scholar
PubMed
What Is Known about This Topic • Thyrogen® is commonly used for serum thyroglobulin testing, for radioiodine ( 131 I) imaging in those patients unwilling to undergo thyroid hormone withdrawal, in patients unable to mount an adequate thyroid-stimulating
Search for other papers by Yasmine Abdellaoui in
Google Scholar
PubMed
Search for other papers by Dimitra Magkou in
Google Scholar
PubMed
Search for other papers by Sofia Bakopoulou in
Google Scholar
PubMed
Search for other papers by Ramona Zaharia in
Google Scholar
PubMed
EA 4340, Université Versailles Saint Quentin en Yvelines, UFR Simone Veil Santé, Montigny le Bretonneux, France
Search for other papers by Marie-Laure Raffin-Sanson in
Google Scholar
PubMed
EA 4340, Université Versailles Saint Quentin en Yvelines, UFR Simone Veil Santé, Montigny le Bretonneux, France
Search for other papers by Laure Cazabat in
Google Scholar
PubMed
coexistence of these two diseases presents a diagnostic challenge. What Does This Case Report Add? Autoimmune hypo- and hyperthyroidism may coexist in kindred with RTHβ. A rapid increase of suppressed thyroid-stimulating hormone
Search for other papers by Caiyan Mo in
Google Scholar
PubMed
Search for other papers by Han Chen in
Google Scholar
PubMed
Search for other papers by Qi Zhang in
Google Scholar
PubMed
Search for other papers by Ying Guo in
Google Scholar
PubMed
Search for other papers by Liyong Zhong in
Google Scholar
PubMed
binding of thyroid-stimulating hormone receptor antibodies (TRAb) to thyroid-stimulating hormone (TSH) receptors leads to unregulated thyroid hormone production independent of pituitary TSH, resulting in hyperthyroidism ( 1 ). Central hyperthyroidism is a
Department of Paediatrics, Southport and Ormskirk NHS Trust, Ormskirk, United Kingdom
Search for other papers by Sze May Ng in
Google Scholar
PubMed
Search for other papers by Mark A. Turner in
Google Scholar
PubMed
Search for other papers by Shivaram Avula in
Google Scholar
PubMed
were calculated. We also prospectively measured thyroid stimulating hormone (TSH) and free thyroxine (FT 4 ) in all infants at the time of recruitment (within 5 days of birth), at days 14, 21, and 28, and at 36 weeks’ CGA. These were measured by solid
Department of Radiology, Jichi Medical University, School of Medicine, Shimotsuke, Tochigi, Japan
Search for other papers by Tomohiro Kikuchi in
Google Scholar
PubMed
Search for other papers by Shouhei Hanaoka in
Google Scholar
PubMed
Search for other papers by Takahiro Nakao in
Google Scholar
PubMed
Center for Frontier Medical Engineering, Chiba University, Yayoicho, Inage–ku, Chiba, Japan
Search for other papers by Yukihiro Nomura in
Google Scholar
PubMed
Search for other papers by Takeharu Yoshikawa in
Google Scholar
PubMed
Search for other papers by Ashraful Alam in
Google Scholar
PubMed
Search for other papers by Harushi Mori in
Google Scholar
PubMed
Search for other papers by Naoto Hayashi in
Google Scholar
PubMed
. The PET images were acquired with the following parameters: FOV, 700 mm; matrix size, 128 × 128; voxel size, 5.47 × 5.47 × 3.25 mm. Hypothyroidism and hyperthyroidism, defined as elevated and decreased thyroid-stimulating hormone (TSH) levels
Search for other papers by Zohar Steinberg Ben-Zeev in
Google Scholar
PubMed
Search for other papers by Marina Peniakov in
Google Scholar
PubMed
Search for other papers by Clari Felszer in
Google Scholar
PubMed
Search for other papers by Scott A Weiner in
Google Scholar
PubMed
Search for other papers by Avishay Lahad in
Google Scholar
PubMed
Search for other papers by Shlomo Almashanu in
Google Scholar
PubMed
The Rappaport Faculty of Medicine, Technion, Institute of Technology, Haifa, Israel
Search for other papers by Yardena Tenenbaum Rakover in
Google Scholar
PubMed
thyrotoxicosis results from thyroid-stimulating immunoglobulin (TSI) crossing the placenta. The presence of thyroid-stimulating hormone (TSH) receptor-blocking antibodies (TBAb) is associated with transient hypothyroidism in the offspring. Antithyroid drugs such